ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Zheng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3758-8165; OpenAlex author ID A5101693590. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 13

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Integrated driver gene-based survival prediction in resected pancreatic cancer. Co-author DOI 10.1093/bjs/znag123 ↗
Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sided pancreatic cancer: a propensity score… Co-author DOI 10.1007/s00464-024-10868-x ↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Christopher R. Shubert · 1 shared paper, 2026 · strength 0.26
- Paper Integrated driver gene-based survival prediction in resected pancreatic cancer. DOI 10.1093/bjs/znag123 ↗
Jin Peng He · 1 shared paper, 2026 · strength 0.26
- Paper Integrated driver gene-based survival prediction in resected pancreatic cancer. DOI 10.1093/bjs/znag123 ↗
Brady A. Campbell · 1 shared paper, 2026 · strength 0.26
- Paper Integrated driver gene-based survival prediction in resected pancreatic cancer. DOI 10.1093/bjs/znag123 ↗
Kelly J. Lafaro · 1 shared paper, 2026 · strength 0.26
- Paper Integrated driver gene-based survival prediction in resected pancreatic cancer. DOI 10.1093/bjs/znag123 ↗
Richard Andrew Burkhart · 1 shared paper, 2026 · strength 0.26
- Paper Integrated driver gene-based survival prediction in resected pancreatic cancer. DOI 10.1093/bjs/znag123 ↗
Marco Dal Molin · 1 shared paper, 2026 · strength 0.26
- Paper Integrated driver gene-based survival prediction in resected pancreatic cancer. DOI 10.1093/bjs/znag123 ↗
Ralph H. Hruban MD · 1 shared paper, 2026 · strength 0.26
- Paper Integrated driver gene-based survival prediction in resected pancreatic cancer. DOI 10.1093/bjs/znag123 ↗
Chen Chen · 1 shared paper, 2024 · strength 0.20
- Paper Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sid… DOI 10.1007/s00464-024-10868-x ↗
Xiaowu Xu · 1 shared paper, 2024 · strength 0.20
- Paper Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sid… DOI 10.1007/s00464-024-10868-x ↗
Qifeng Zhuo · 1 shared paper, 2024 · strength 0.20
- Paper Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sid… DOI 10.1007/s00464-024-10868-x ↗
Wensheng Liu · 1 shared paper, 2024 · strength 0.20
- Paper Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sid… DOI 10.1007/s00464-024-10868-x ↗
Chenjie Zhou · 1 shared paper, 2024 · strength 0.20
- Paper Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sid… DOI 10.1007/s00464-024-10868-x ↗
Xianjun Yu · 1 shared paper, 2024 · strength 0.20
- Paper Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sid… DOI 10.1007/s00464-024-10868-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.